SR-B1 activation has been shown to modulate the inhibition of platelet aggregation in vitro [144], and reduced expression of SR-B1, PDZK1, and Akt1 have been shown to increase the risk of spontaneous or diet induced coronary artery atherosclerosis and myocardial infarction in mice [150]. Here, SCARB1 is linked to coronary atherosclerosis.